A Comparison Between Biportal and Uniportal Endoscopic Lumbar Discectomy
NCT ID: NCT07151651
Last Updated: 2025-09-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
60 participants
INTERVENTIONAL
2025-09-01
2027-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sagittal Parameters After Mono Segmental Lumber Fusion: Interbody Versus Postrolateral Fusion
NCT03877341
Clinical Evaluation of Re-treatment of Cleft Lip and Nasal Deformation in Patients With Post Repair Deformities
NCT07348185
Gluteus Maximus Versus Gluteus Medius Strength On Back Muscles Performance In Patients With Sacroiliac Dysfunction
NCT05809206
Dorsal Finger Reconstruction
NCT04961879
Comparison Between Strain-counterstrain and Muscle Energy Technique in Sacroiliac Joint Dysfunction
NCT04717401
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with lumbar disc prolapse
1. Patients aged 18-70 years.
2. single-level lumbar disc herniation (L3-L4, L4-L5, or L5-S1) confirmed by MRI.
3. Persistent symptoms not responding to conservative management (≥6 weeks).
Endoscopic lumbar discectomy
Uniportal and boportal endoscopic lumbar discectomy (transforaminal or interlaminar)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endoscopic lumbar discectomy
Uniportal and boportal endoscopic lumbar discectomy (transforaminal or interlaminar)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Patients aged 18-70 years.
2. single-level lumbar disc herniation (L3-L4, L4-L5, or L5-S1) confirmed by MRI.
3. Persistent symptoms not responding to conservative management (≥6 weeks).
Exclusion Criteria
1. Multilevel disc herniation.
2. Previous lumbar spine surgery, trauma or injection.
3. Severe spinal stenosis.
4. Severe osteoporosis, infection, or malignancy or autoimmune disease affecting the spine.
5. Uncontrolled medical comorbidities contraindicating surgery.
6. Instability: spondylolisthesis\>grade 1
7. Marked obesity.(BMI \>35-40 kg/m2 )
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Ibraheem Amin
Assistant lecturer at neurosurgery department sohag University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sohag University
Sohag, Sohag Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
mohamed Ibrahim Amin, Assesstant lecturer
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Sohag-Med-25-8---4MD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.